Oxford Biomedica plc (LSE:OXB) entered into a sale and purchase agreement to acquire ABL EUROPE S.A.S. from TSGH for ?15 million on December 4, 2023. Completion of the transaction is currently expected to take place in the first quarter of 2024 subject to the satisfaction and waiver of outstanding conditions, including obtaining the necessary regulatory approvals.